United States Blood Lancets Market Report 2016

United States Blood Lancets Market Report 2016

1 Blood Lancets Overview

1.1 Product Overview and Scope of Blood Lancets

1.2 Classification of Blood Lancets

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Blood Lancets

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Blood Lancets (2011-2021)

1.4.1 United States Blood Lancets Sales and Growth Rate (2011-2021)

1.4.2 United States Blood Lancets Revenue and Growth Rate (2011-2021)

2 United States Blood Lancets Competition by Manufacturers

2.1 United States Blood Lancets Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Blood Lancets Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Blood Lancets Average Price by Manufactures (2015 and 2016)

2.4 Blood Lancets Market Competitive Situation and Trends

2.4.1 Blood Lancets Market Concentration Rate

2.4.2 Blood Lancets Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Blood Lancets Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Blood Lancets Sales and Market Share by Type (2011-2016)

3.2 United States Blood Lancets Revenue and Market Share by Type (2011-2016)

3.3 United States Blood Lancets Price by Type (2011-2016)

3.4 United States Blood Lancets Sales Growth Rate by Type (2011-2016)

4 United States Blood Lancets Sales (Volume) by Application (2011-2016)

4.1 United States Blood Lancets Sales and Market Share by Application (2011-2016)

4.2 United States Blood Lancets Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Blood Lancets Manufacturers Profiles/Analysis

5.1 AdvaCare Pharmaceuticals (China)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Blood Lancets Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 AdvaCare Pharmaceuticals (China) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Beckman Coulter, Inc. (US)

5.2.2 Blood Lancets Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Beckman Coulter, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Becton, Dickinson and Company (US)

5.3.2 Blood Lancets Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Becton, Dickinson and Company (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Fresenius Kabi AG (Germany)

5.4.2 Blood Lancets Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Fresenius Kabi AG (Germany) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Fenwal, Inc. (US)

5.5.2 Blood Lancets Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Fenwal, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Grifols International S.A. (Spain)

5.6.2 Blood Lancets Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Grifols International S.A. (Spain) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Haemonetics Corporation (US)

5.7.2 Blood Lancets Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Haemonetics Corporation (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Immucor, Inc. (US)

5.8.2 Blood Lancets Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Immucor, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 JMS Co. Ltd. (Japan)

5.9.2 Blood Lancets Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 JMS Co. Ltd. (Japan) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Kawasumi Laboratories, Inc. (Japan)

5.10.2 Blood Lancets Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Kawasumi Laboratories, Inc. (Japan) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 MacoPharma SA (France)

5.12 Shanghai Transfusion Technology Co., Ltd. (China)

5.13 Stago (France)

5.14 Terumo Corporation (Japan)

5.15 Terumo BCT, Inc. (US)

6 Blood Lancets Manufacturing Cost Analysis

6.1 Blood Lancets Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Blood Lancets

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Blood Lancets Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Blood Lancets Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Blood Lancets Market Forecast (2016-2021)

10.1 United States Blood Lancets Sales, Revenue Forecast (2016-2021)

10.2 United States Blood Lancets Sales Forecast by Type (2016-2021)

10.3 United States Blood Lancets Sales Forecast by Application (2016-2021)

10.4 Blood Lancets Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Blood Lancets

Table Classification of Blood Lancets

Figure United States Sales Market Share of Blood Lancets by Type in 2015

Table Application of Blood Lancets

Figure United States Sales Market Share of Blood Lancets by Application in 2015

Figure United States Blood Lancets Sales and Growth Rate (2011-2021)

Figure United States Blood Lancets Revenue and Growth Rate (2011-2021)

Table United States Blood Lancets Sales of Key Manufacturers (2015 and 2016)

Table United States Blood Lancets Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Blood Lancets Sales Share by Manufacturers

Figure 2016 Blood Lancets Sales Share by Manufacturers

Table United States Blood Lancets Revenue by Manufacturers (2015 and 2016)

Table United States Blood Lancets Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Blood Lancets Revenue Share by Manufacturers

Table 2016 United States Blood Lancets Revenue Share by Manufacturers

Table United States Market Blood Lancets Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Blood Lancets Average Price of Key Manufacturers in 2015

Figure Blood Lancets Market Share of Top 3 Manufacturers

Figure Blood Lancets Market Share of Top 5 Manufacturers

Table United States Blood Lancets Sales by Type (2011-2016)

Table United States Blood Lancets Sales Share by Type (2011-2016)

Figure United States Blood Lancets Sales Market Share by Type in 2015

Table United States Blood Lancets Revenue and Market Share by Type (2011-2016)

Table United States Blood Lancets Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Blood Lancets by Type (2011-2016)

Table United States Blood Lancets Price by Type (2011-2016)

Figure United States Blood Lancets Sales Growth Rate by Type (2011-2016)

Table United States Blood Lancets Sales by Application (2011-2016)

Table United States Blood Lancets Sales Market Share by Application (2011-2016)

Figure United States Blood Lancets Sales Market Share by Application in 2015

Table United States Blood Lancets Sales Growth Rate by Application (2011-2016)

Figure United States Blood Lancets Sales Growth Rate by Application (2011-2016)

Table AdvaCare Pharmaceuticals (China) Basic Information List

Table AdvaCare Pharmaceuticals (China) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AdvaCare Pharmaceuticals (China) Blood Lancets Sales Market Share (2011-2016)

Table Beckman Coulter, Inc. (US) Basic Information List

Table Beckman Coulter, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Beckman Coulter, Inc. (US) Blood Lancets Sales Market Share (2011-2016)

Table Becton, Dickinson and Company (US) Basic Information List

Table Becton, Dickinson and Company (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Becton, Dickinson and Company (US) Blood Lancets Sales Market Share (2011-2016)

Table Fresenius Kabi AG (Germany) Basic Information List

Table Fresenius Kabi AG (Germany) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fresenius Kabi AG (Germany) Blood Lancets Sales Market Share (2011-2016)

Table Fenwal, Inc. (US) Basic Information List

Table Fenwal, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fenwal, Inc. (US) Blood Lancets Sales Market Share (2011-2016)

Table Grifols International S.A. (Spain) Basic Information List

Table Grifols International S.A. (Spain) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Grifols International S.A. (Spain) Blood Lancets Sales Market Share (2011-2016)

Table Haemonetics Corporation (US) Basic Information List

Table Haemonetics Corporation (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Haemonetics Corporation (US) Blood Lancets Sales Market Share (2011-2016)

Table Immucor, Inc. (US) Basic Information List

Table Immucor, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Immucor, Inc. (US) Blood Lancets Sales Market Share (2011-2016)

Table JMS Co. Ltd. (Japan) Basic Information List

Table JMS Co. Ltd. (Japan) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table JMS Co. Ltd. (Japan) Blood Lancets Sales Market Share (2011-2016)

Table Kawasumi Laboratories, Inc. (Japan) Basic Information List

Table Kawasumi Laboratories, Inc. (Japan) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kawasumi Laboratories, Inc. (Japan) Blood Lancets Sales Market Share (2011-2016)

Table MacoPharma SA (France) Basic Information List

Table MacoPharma SA (France) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table MacoPharma SA (France) Blood Lancets Sales Market Share (2011-2016)

Table Shanghai Transfusion Technology Co., Ltd. (China) Basic Information List

Table Shanghai Transfusion Technology Co., Ltd. (China) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shanghai Transfusion Technology Co., Ltd. (China) Blood Lancets Sales Market Share (2011-2016)

Table Stago (France) Basic Information List

Table Stago (France) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Stago (France) Blood Lancets Sales Market Share (2011-2016)

Table Terumo Corporation (Japan) Basic Information List

Table Terumo Corporation (Japan) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Terumo Corporation (Japan) Blood Lancets Sales Market Share (2011-2016)

Table Terumo BCT, Inc. (US) Basic Information List

Table Terumo BCT, Inc. (US) Blood Lancets Sales, Revenue, Price and Gross Margin (2011-2016)

Table Terumo BCT, Inc. (US) Blood Lancets Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Blood Lancets

Figure Manufacturing Process Analysis of Blood Lancets

Figure Blood Lancets Industrial Chain Analysis

Table Raw Materials Sources of Blood Lancets Major Manufacturers in 2015

Table Major Buyers of Blood Lancets

Table Distributors/Traders List

Figure United States Blood Lancets Production and Growth Rate Forecast (2016-2021)

Figure United States Blood Lancets Revenue and Growth Rate Forecast (2016-2021)

Table United States Blood Lancets Production Forecast by Type (2016-2021)

Table United States Blood Lancets Consumption Forecast by Application (2016-2021)